TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels—one inflammatory and one protective. This protein, a ...

Sumitomo Pharma Co. Ltd. has patented aminomethylcyclohexane derivatives acting as muscarinic M4 receptor antagonists. As such, they are described as potentially useful for the treatment of ...

Opportunities in the GLP-1 receptor agonist market include the development of new diabetes and obesity treatments with high ...

A single receptor in blood vessels can trigger either harmful inflammation or protective healing, but scientists have ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

Retrospective study finds link between blockbuster drugs and longer survival ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...

Exercise is known to improve mood and memory, but the biological pathways connecting physical activity to brain function remain not entirely understood. In a new study published in Brain Medicine, ...

Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to ...

Florida Atlantic University has received a $2.4 million grant from the National Institutes of Health to investigate how an immune-related receptor in neurons plays a fundamental role in brain function ...